2026-07-03 • Psychedelics Today

Psychedelics Today at the Aspen Psychedelic Symposium

Psychedelics Today founder Joe Moore hosted two panels at the Aspen Psychedelic Symposium, now available through Aspen Public Radio: one on novel and preclinical psychedelic uses, and one on how families can talk with young people about drugs. The post Psychedelics Today at the Aspen Psychedelic Symposium appeared first on Psychedelics Today.

External link. We are not responsible for the content.

Read more ↗

More From Psychedelics Today

2026-07-03 • Psychedelics Today

The Framework Gap in Psychedelic Practice: An Introduction to the 8-Circuit Model of Consciousness

Western clinical frameworks were built to reduce pathology, not to map what happens when a client encounters ancestra...

2026-06-30 • Psychedelics Today

Psychedelic Policy Briefing: Week of June 29nd, 2026

Massachusetts advances two psychedelic therapy pilot bills, Louisiana's opioid-settlement-funded program takes effect...

2026-06-29 • Psychedelics Today

A Country That Recalls Its Own Forgetting

Between the 1930s and 1960s, Italian clinics ran psychedelic experiments on hundreds of patients, then forgot they ev...

Latest News

2026-07-03 • The Psychedelic Blog (Substack)

The Status Games Forrest Never Played

Welcome to The Psychedelic Blog.

2026-07-03 • DoubleBlind Magazine

Could Psychedelics Change Donald Trump?

We took a deep dive into the science of psychedelics and how they impact authoritarian attitudes. [...] Read More......

2026-07-03 • Psychedelic Press (Substack)

What Makes Music Psychedelic?

Repetition, Perception, and Form in the Music of Terry Riley

2026-07-02 • PsyMed Ventures

The State of Frontier Neuroscience: This is the century of the brain.

Why now, what’s investable & who wins.

2026-07-01 • DoubleBlind Magazine

Synthetic Psilocybin Doesn’t Produce the Entourage Effect

The effects of full-spectrum psilocybin could have implications for the future of psilocybin-assisted therapy. [...] ...

2026-06-30 • MAPS

Protected: MAPS Publishes Ibogaine Investigator’s Brochure as a Free, Open-Access Resource

There is no excerpt because this is a protected post.